Citations (8)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Huy Hao Dao & Pierre Moreau. (2001) An update on the status of endothelin receptor antagonists for hypertension. Expert Opinion on Investigational Drugs 10:11, pages 1937-1946.
Read now
Read now
Articles from other publishers (7)
John R. Teerlink. 2008. Acute Heart Failure. Acute Heart Failure
626
638
.
Ming-Fu Cheng, Hui-Ming Yu, Bor-Wen Ko, Yu Chang, Ming-Yi Chen, Tong-Ing Ho, Yeun-Min Tsai & Jim-Min Fang. (2006)
Practical synthesis of potential endothelin receptor antagonists of 1,4-benzodiazepine-2,5-dione derivatives bearing substituents at the C
3
-, N
1
- and N
4
-positions
. Org. Biomol. Chem. 4:3, pages 510-518.
Crossref
Crossref
Gabriel Vorobiof, Burns C. Blaxall & John D. Bisognano. (2006) The future of endothelin-receptor antagonism as treatment for systemic hypertension. Current Hypertension Reports 8:1, pages 35-44.
Crossref
Crossref
P. Moreau, M.-A. Laplante, P. Beaucage & J. de Champlain. 2004. Angiotensin Vol. I. Angiotensin Vol. I
149
170
.
Pierre Moreau & Ernesto L Schiffrin. (2003) Role of endothelins in animal models of hypertension: focus on cardiovascular protection. Canadian Journal of Physiology and Pharmacology 81:6, pages 511-521.
Crossref
Crossref
Huy Hao Dao, Jacinthe Lemay, Jacques de Champlain, Denis deBlois & Pierre Moreau. (2001) Norepinephrine-induced aortic hyperplasia and extracellular matrix deposition are endothelin-dependent. Journal of Hypertension 19:11, pages 1965-1973.
Crossref
Crossref
Jidong Zhang, Stanislas Didierlaurent, Michel Fortin, Dominique Lefrançois, Eric Uridat & Jean Paul Vevert. (2000) Nonpeptide endothelin antagonists: from lower affinity pyrazol-5-ols to higher affinity pyrazole-5-carboxylic acids. Bioorganic & Medicinal Chemistry Letters 10:12, pages 1351-1355.
Crossref
Crossref